SCHEMBL9873189

SCHEMBL9873189

CCCCc1nc(CO)c(C(=O)OC)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 5/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
PARP1 P09874 1/20 0.35
TUBB4A P04350 2/20 0.34
TUBB P07437 2/20 0.34
TUBA3C P0DPH7 2/20 0.34
TUBA1B P68363 2/20 0.34
TUBA4A P68366 2/20 0.34
TUBB4B P68371 2/20 0.34
TUBB3 Q13509 2/20 0.34
TUBB2A Q13885 2/20 0.34
TUBB8 Q3ZCM7 2/20 0.34
TUBA3E Q6PEY2 2/20 0.34
TUBA1A Q71U36 2/20 0.34
TUBA1C Q9BQE3 2/20 0.34
TUBB6 Q9BUF5 2/20 0.34
TUBB2B Q9BVA1 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27336186 0.90 GPR84 (0.36) GPR84NPC1RAB9AALDH1A1MAPK1
SCHEMBL27446408 0.85 ALDH1A1 (0.34) GPR84ALDH1A1MAPK1PARP1TLR7
SCHEMBL27322051 0.84 PARP1 (0.40) GPR84ALDH1A1MAPK1PARP1LMNA
SCHEMBL27318209 0.83 GPR84 (0.38) GPR84ALDH1A1MAPK1PARP1GSK3B
SCHEMBL7303318 0.83 NPSR1 (0.41) GPR84NPC1RAB9AALDH1A1MAPK1
SCHEMBL27334926 0.83 GPR84 (0.41) GPR84NPC1RAB9AALDH1A1MAPK1
SCHEMBL8812731 0.82 GPR84 (0.42) GPR84MAPT
SCHEMBL833 0.82 GPR84 (0.37) GPR84NPC1RAB9AALDH1A1MAPK1
SCHEMBL27542325 0.82 GPR84 (0.37) GPR84NPC1RAB9AALDH1A1MAPK1
SCHEMBL7398766 0.81 HPGD (0.37) NPC1RAB9AALDH1A1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1121859-C Process for preparing pharmaceutical composition for treatment or prevention hypertension SNAKYO CO LTD (JP) 2003-09-24 CN disclosed
CN-1101384-C Process for preparing 1-biphenylmethylimidazole derivatives SANKYO CO (JP) 2003-02-12 CN disclosed
CN-1045770-C Process for preparing 1-biphenylmethylimidazole derivatives SANKYO CO (JP) 1999-10-20 CN disclosed
CN-1189490-A Process for preparing 1-biphenylmethylimidazole derivatives SANKYO CO (JP) 1998-08-05 CN disclosed
CN-1188645-A Process for preparing pharmaceutical composition for treatment or prevention hypertension SNAKYO CO LTD (JP) 1998-07-29 CN disclosed
CN-1065063-A 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1992-10-07 CN disclosed
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO disclosed